Eisai Announces Investigational Data Highlighting LENVIMA® (lenvatinib) Based Combination Therapy in Patients With Renal Cell Carcinoma at IKCS 2020 ...Middle East

WOODCLIFF LAKE, N.J., Nov. 5, 2020 /PRNewswire/ -- Eisai will present seven abstracts at the International Kidney Cancer Symposium (IKCS) 2020 from November 6-7, 2020. New investigational data from Study 218, a Phase 2 trial evaluating the safety and efficacy of two starting doses (14 mg...

Read More Details
Finally We wish PressBee provided you with enough information of ( Eisai Announces Investigational Data Highlighting LENVIMA® (lenvatinib) Based Combination Therapy in Patients With Renal Cell Carcinoma at IKCS 2020 )

Also on site :

• Wall Street’s advice after Nvidia hits historic $4 trillion market cap: BUY
• Cheez-Its confirms huge recipe change – new crackers are missing a key ingredient from the original version
• Israel arrests 50 across occupied West Bank; Jenin displaced return briefly